col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

MDPI AG: Vaccines
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―19 Acceptance of COVID-19 Vaccination in Cancer Patients in Hong Kong: Approaches to Improve the Vaccination Rate Wing-Lok Chan, Yuen-Hung Tricia Ho, Carlos King-Ho Wong, Horace Cheuk-Wai Choi, Ka-On Lam, Kwok-Keung Yuen, et al. (+2)
2 [GO] 2021―Jul―19 Young Adults’ Intentions and Rationales for COVID-19 Vaccination Participation: Evidence from a Student Survey in Ho Chi Minh City, Vietnam Quy Van Khuc, Trang Nguyen, Thuy Nguyen, Linh Pham, Dang-Trung Le, Hong-Hai Ho, et al. (+2)
3 [GO] 2021―Jul―19 Bioinformatics Prediction of SARS-CoV-2 Epitopes as Vaccine Candidates for the Colombian Population Diana Montes-Grajales, Jesus Olivero-Verbel
4 [GO] 2021―Jul―16 The Long and Winding Road: Uptake, Acceptability, and Potential Influencing Factors of COVID-19 Vaccination in Austria Isabel King, Petra Heidler, Roy Rillera Marzo
5 [GO] 2021―Jul―15 Efficiency in COVID-19 Vaccination Campaigns-A Comparison across Germany’s Federal States Georg Götz, Daniel Herold, Phil-Adrian Klotz, Jan Thomas Schäfer
6 [GO] 2021―Jul―14 COVID-19 Vaccine mRNABNT162b2 Elicits Human Antibody Response in Milk of Breastfeeding Women Maurizio Guida, Daniela Terracciano, Michele Cennamo, Federica Aiello, Evelina La Civita, Gennaro Esposito, et al. (+4)
7 [GO] 2021―Jul―13 COVID-19 Vaccination Acceptance and Hesitancy among Healthcare Workers in Germany Christopher Holzmann-Littig, Matthias Christoph Braunisch, Peter Kranke, Maria Popp, Christian Seeber, Falk Fichtner, et al. (+7)
8 [GO] 2021―Jul―13 Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants Vladimir A. Gushchin, Inna V. Dolzhikova, Alexey M. Shchetinin, Alina S. Odintsova, Andrei E. Siniavin, Maria A. Nikiforova, et al. (+24)
9 [GO] 2021―Jul―12 Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations Verónica Cabreira, Pedro Abreu, Ricardo Soares-dos-Reis, Joana Guimarães, Maria José Sá
10 [GO] 2021―Jul―09 Healthcare Workers’ Willingness to Receive Influenza Vaccination in the Context of the COVID-19 Pandemic: A Survey in Southern Italy Gabriella Di Giuseppe, Concetta P. Pelullo, Andrea Paolantonio, Giorgia Della Polla, Maria Pavia
11 [GO] 2021―Jul―09 Evaluation of Flu Vaccination Coverage among Healthcare Workers during a 3 Years’ Study Period and Attitude towards Influenza and Potential COVID-19 Vaccination in the Context of the Pandemic Giuditta Scardina, Luca Ceccarelli, Virginia Casigliani, Sara Mazzilli, Marco Napoletano, Martina Padovan, et al. (+9)
12 [GO] 2021―Jul―09 Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination Elena Savoia, Rachael Piltch-Loeb, Beth Goldberg, Cynthia Miller-Idriss, Brian Hughes, Alberto Montrond, et al. (+2)
13 [GO] 2021―Jul―09 Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2 Tuksin Jearanaiwitayakul, Mathurin Seesen, Runglawan Chawengkirttikul, Jitra Limthongkul, Suttikarn Apichirapokey, Sompong Sapsutthipas, et al. (+3)
14 [GO] 2021―Jul―09 A Quantitative ELISA Protocol for Detection of Specific Human IgG Against the SARS-CoV-2 Spike Protein Rémi Vernet, Emily Charrier, Julien Grogg, Nicolas Mach
15 [GO] 2021―Jul―08 Exploring Psychological Factors for COVID-19 Vaccination Intention in Taiwan Shih-Yu Lo, Shu-Chu Sarrina Li, Tai-Yee Wu
16 [GO] 2021―Jul―08 Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives Gerardo Cazzato, Paolo Romita, Caterina Foti, Antonietta Cimmino, Anna Colagrande, Francesca Arezzo, et al. (+5)
17 [GO] 2021―Jul―08 Can Communication Strategies Combat COVID-19 Vaccine Hesitancy with Trade-Off between Public Service Messages and Public Skepticism? Experimental Evidence from Pakistan Qiang Jin, Syed Hassan Raza, Muhammad Yousaf, Umer Zaman, Jenny Marisa Lim Dao Siang
18 [GO] 2021―Jul―08 Experiences with Testing, Self-Isolation and Vaccination in North East England during the COVID Pandemic Richard Harris
19 [GO] 2021―Jul―08 Willingness to Receive the COVID-19 and Seasonal Influenza Vaccines among the Saudi Population and Vaccine Uptake during the Initial Stage of the National Vaccination Campaign: A Cross-Sectional Survey Amel Ahmed Fayed, Abeer Salem Al Shahrani, Leenah Tawfiq Almanea, Nardeen Ibrahim Alsweed, Layla Mohammed Almarzoug, Reham Ibrahim Almuwallad, Waad Fahad Almugren
20 [GO] 2021―Jul―07 Accelerated Development of COVID-19 Vaccines: Technology Platforms, Benefits, and Associated Risks Ralf Wagner, Eberhard Hildt, Elena Grabski, Yuansheng Sun, Heidi Meyer, Annette Lommel, et al. (+3)
21 [GO] 2021―Jul―07 Immune Responses to Pandemic H1N1 Influenza Virus Infection in Pigs Vaccinated with a Conserved Hemagglutinin HA1 Peptide Adjuvanted with CAF®01 or CDA/αGalCerMPEG Sergi López-Serrano, Lorena Cordoba, Mónica Pérez-Maillo, Patricia Pleguezuelos, Edmond J. Remarque, Thomas Ebensen, et al. (+4)
22 [GO] 2021―Jul―06 Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection José Javier Morales-Núñez, José Francisco Muñoz-Valle, Carlos Meza-López, Lin-Fa Wang, Andrea Carolina Machado Sulbarán, Paola Carolina Torres-Hernández, et al. (+4)
23 [GO] 2021―Jul―06 COVID-19 Pandemic Optimism and Vaccine Willingness among an Online Sample of US Gay, Bisexual, and Other Men Who Have Sex with Men Rob Stephenson, Stephen P. Sullivan, Renee A. Pitter, Alexis S. Hunter, Tanaka MD Chavanduka
24 [GO] 2021―Jul―06 Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations Konlavat Siriwattananon, Suwimon Manopwisedjaroen, Balamurugan Shanmugaraj, Eakachai Prompetchara, Chutitorn Ketloy, Supranee Buranapraditkun, et al. (+5)
25 [GO] 2021―Jul―05 COVID-19 Pandemic Development in Jordan-Short-Term and Long-Term Forecasting Tareq Hussein, Mahmoud H. Hammad, Pak Lun Fung, Marwan Al-Kloub, Issam Odeh, Martha A. Zaidan, Darren Wraith
26 [GO] 2021―Jul―05 Retraction: Walach et al. The Safety of COVID-19 Vaccinations-We Should Rethink the Policy. Vaccines 2021, 9, 693
27 [GO] 2021―Jul―05 Understanding Soaring Coronavirus Cases and the Effect of Contagion Policies in the UK Miguel A. Durán-Olivencia, Serafim Kalliadasis
28 [GO] 2021―Jul―05 Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell Responses Kirsi Tamminen, Suvi Heinimäki, Stina Gröhn, Vesna Blazevic
29 [GO] 2021―Jul―05 Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients-A Single-Center Experience Jassin Rashidi-Alavijeh, Alexandra Frey, Moritz Passenberg, Johannes Korth, Jaqueline Zmudzinski, Olympia E. Anastasiou, et al. (+4)
30 [GO] 2021―Jul―02 Vectored-Vaccine Platforms Enabled Rapid Development of Safe and Effective Vaccines in Response to COVID-19 Pandemic Situation Amine A. Kamen
31 [GO] 2021―Jul―01 A Novel Vaccine Selection Decision-Making Model (VSDMM) for COVID-19 Sayed F. Abdelwahab, Usama H. Issa, Hossam M. Ashour
32 [GO] 2021―Jul―01 Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study Marco Massari, Stefania Spila-Alegiani, Massimo Fabiani, Valeria Belleudi, Gianluca Trifirò, Ursula Kirchmayer, et al. (+12)
33 [GO] 2021―Jul―01 A National Survey to Assess the COVID-19 Vaccine-Related Conspiracy Beliefs, Acceptability, Preference, and Willingness to Pay among the General Population of Pakistan Muhammad Subhan Arshad, Iltaf Hussain, Tahir Mahmood, Khezar Hayat, Abdul Majeed, Imran Imran, et al. (+16)
34 [GO] 2021―Jul―01 Influenza Vaccination Coverage and Intention to Receive Hypothetical Ebola and COVID-19 Vaccines among Medical Students Ewa Talarek, Joanna Warzecha, Marcin Banasiuk, Aleksandra Banaszkiewicz
35 [GO] 2021―Jul―01 Signatures of the Venezuelan Humanitarian Crisis in the First Wave of COVID-19: Fuel Shortages and Border Migration Margarita Lampo, Juan V. Hernández-Villena, Jaime Cascante, María F. Vincenti-González, David A. Forero-Peña, Maikell J. Segovia, et al. (+3)
36 [GO] 2021―Jul―01 Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients Emanuele Amodio, Giuseppina Capra, Alessandra Casuccio, Simona De Grazia, Dario Genovese, Stefano Pizzo, et al. (+5)
37 [GO] 2021―Jul―01 High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events Evangelos Terpos, Marianna Politou, Ioannis Ntanasis-Stathopoulos, Vangelis Karalis, Efrosyni Merkouri, Despina Fotiou, et al. (+5)
38 [GO] 2021―Jun―30 SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor Anna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, Rui Costa, Nandini Prabhakar Venkatesan, Xiangliang Lin, et al. (+9)
39 [GO] 2021―Jun―30 Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines Madhusudhanan Narasimhan, Lenin Mahimainathan, Andrew E Clark, Amena Usmani, Jing Cao, Ellen Araj, et al. (+5)
40 [GO] 2021―Jun―28 Expression of Concern: Walach et al. The Safety of COVID-19 Vaccinations-We Should Rethink the Policy. Vaccines 2021, 9, 693 Vaccines Editorial Office
41 [GO] 2021―Jun―28 Real-World Acceptance of COVID-19 Vaccines among Healthcare Workers in Perinatal Medicine in China Biyun Xu, Xuelian Gao, Xinyue Zhang, Yali Hu, Huixia Yang, Yi-Hua Zhou
42 [GO] 2021―Jun―28 Multi-Subunit SARS-CoV-2 Vaccine Design Using Evolutionarily Conserved T- and B- Cell Epitopes Burkitkan Akbay, Syed Hani Abidi, Mahmoud A. A. Ibrahim, Zhussipbek Mukhatayev, Syed Ali
43 [GO] 2021―Jun―25 Characteristics of Healthcare Workers Vaccinated against Influenza in the Era of COVID-19 Giorgia Della Polla, Francesca Licata, Silvia Angelillo, Concetta Paola Pelullo, Aida Bianco, Italo Francesco Angelillo
44 [GO] 2021―Jun―25 The Safety of COVID-19 Vaccinations-We Should Rethink the Policy Harald Walach, Rainer J. Klement, Wouter Aukema
45 [GO] 2021―Jun―25 Predictors of Intention to Vaccinate against COVID-19 in the General Public in Hong Kong: Findings from a Population-Based, Cross-Sectional Survey Elsie Yan, Daniel W. L. Lai, Vincent W. P. Lee
46 [GO] 2021―Jun―25 Modeling the Impact of COVID-19 Vaccination in Lebanon: A Call to Speed-Up Vaccine Roll Out Ghina R. Mumtaz, Fadi El-Jardali, Mathilda Jabbour, Aya Harb, Laith J. Abu-Raddad, Monia Makhoul
47 [GO] 2021―Jun―25 Psychological Determinants of COVID-19 Vaccine Acceptance among Healthcare Workers in Kuwait: A Cross-Sectional Study Using the 5C and Vaccine Conspiracy Beliefs Scales Mariam Al-Sanafi, Malik Sallam
48 [GO] 2021―Jun―25 Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination Franziska Neumann, Ruben Rose, Janine Römpke, Olaf Grobe, Thomas Lorentz, Helmut Fickenscher, Andi Krumbholz
49 [GO] 2021―Jun―24 COVID-19 and the Gaping Wounds of South Africa’s Suboptimal Immunisation Coverage: An Implementation Research Imperative for Assessing and Addressing Missed Opportunities for Vaccination Chukwudi A. Nnaji, Charles S. Wiysonge, Maia Lesosky, Hassan Mahomed, Duduzile Ndwandwe
50 [GO] 2021―Jun―23 Fear of COVID-19 and Perceived COVID-19 Infectability Supplement Theory of Planned Behavior to Explain Iranians’ Intention to Get COVID-19 Vaccinated Rafat Yahaghi, Safie Ahmadizade, Razie Fotuhi, Elham Taherkhani, Mehdi Ranjbaran, Zeinab Buchali, et al. (+13)
51 [GO] 2021―Jun―23 Early Onset of SARS-COV-2 Antibodies after First Dose of BNT162b2: Correlation with Age, Gender and BMI Raul Pellini, Aldo Venuti, Fulvia Pimpinelli, Elva Abril, Giovanni Blandino, Flaminia Campo, et al. (+23)
52 [GO] 2021―Jun―21 Evaluation of SARS-CoV-2 Spike Protein Antibody Titers in Cord Blood after COVID-19 Vaccination during Pregnancy in Polish Healthcare Workers: Preliminary Results Wojciech Zdanowski, Tomasz Waśniewski
53 [GO] 2021―Jun―21 COVID-19 Vaccine Acceptance in Azuay Province, Ecuador: A Cross-Sectional Online Survey Julio Jaramillo-Monge, Michael Obimpeh, Bernardo Vega, David Acurio, Annelies Boven, Veronique Verhoeven, Robert Colebunders
54 [GO] 2021―Jun―21 Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States Abanoub Riad, Andrea Pokorná, Mohamed Mekhemar, Jonas Conrad, Jitka Klugarová, Michal Koščík, et al. (+2)
55 [GO] 2021―Jun―21 Attitudes towards the COVID-19 Vaccine and Willingness to Get Vaccinated among Healthcare Workers in French Guiana: The Influence of Geographical Origin Nicolas Vignier, Kepha Brureau, Sybille Granier, Jacques Breton, Céline Michaud, Mélanie Gaillet, et al. (+9)
56 [GO] 2021―Jun―21 Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia Abdulaziz Alhazmi, Edrous Alamer, Dalia Daws, Mashael Hakami, Majid Darraj, Siddig Abdelwahab, et al. (+2)
57 [GO] 2021―Jun―21 BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers Federico Pratesi, Teresita Caruso, Davide Testa, Tiziano Tarpanelli, Alessandra Gentili, Davide Gioè, Paola Migliorini
58 [GO] 2021―Jun―18 Global Trends and Correlates of COVID-19 Vaccination Hesitancy: Findings from the iCARE Study Jovana Stojanovic, Vincent G. Boucher, Myriam Gagne, Samir Gupta, Keven Joyal-Desmarais, Stefania Paduano, et al. (+6)
59 [GO] 2021―Jun―18 COVID-19 Vaccine Hesitancy and Its Associated Factors in Japan Ryo Okubo, Takashi Yoshioka, Satoko Ohfuji, Takahiro Matsuo, Takahiro Tabuchi
60 [GO] 2021―Jun―18 First Dose of the BNT162b2 mRNA COVID-19 Vaccine Reduces Symptom Duration and Viral Clearance in Healthcare Workers Luca Coppeta, Ottavia Balbi, Zaira Grattagliano, Grazia Genga Mina, Antonio Pietroiusti, Andrea Magrini, et al. (+2)
61 [GO] 2021―Jun―18 Immune Response to Vaccination against COVID-19 in Breastfeeding Health Workers Katarzyna Jakuszko, Katarzyna Kościelska-Kasprzak, Marcelina Żabińska, Dorota Bartoszek, Paweł Poznański, Dagna Rukasz, et al. (+3)
62 [GO] 2021―Jun―18 Acceptance of COVID-19 Vaccine among the Healthcare Workers in the Eastern Cape, South Africa: A Cross Sectional Study Oladele Vincent Adeniyi, David Stead, Mandisa Singata-Madliki, Joanne Batting, Matthew Wright, Eloise Jelliman, et al. (+2)
63 [GO] 2021―Jun―18 COVID-19 Vaccine Hesitancy in a Representative Education Sector Population in Qatar Reem Al-Mulla, Marawan Abu-Madi, Qusai M. Talafha, Reema F. Tayyem, Atiyeh M. Abdallah
64 [GO] 2021―Jun―16 Antivaccine Movement and COVID-19 Negationism: A Content Analysis of Spanish-Written Messages on Twitter Ivan Herrera-Peco, Beatriz Jiménez-Gómez, Carlos Santiago Romero Magdalena, Juan José Deudero, María García-Puente, Elvira Benítez De Gracia, Carlos Ruiz Núñez
65 [GO] 2021―Jun―16 COVID-19 Vaccine Acceptance, Hesitancy, and Resistancy among University Students in France Marie Pierre Tavolacci, Pierre Dechelotte, Joel Ladner
66 [GO] 2021―Jun―15 Attitude towards Vaccination among Health Science Students before the COVID-19 Pandemic Pérez-Rivas Francisco Javier, Del Gallego-Lastra Ramón, Esteban-Garcimartín Ana, Marques-Vieira Cristina Maria Alves, Ajejas Bazán María Julia
67 [GO] 2021―Jun―15 A Comparison of Vaccine Hesitancy of COVID-19 Vaccination in China and the United States Taoran Liu, Zonglin He, Jian Huang, Ni Yan, Qian Chen, Fengqiu Huang, et al. (+6)
68 [GO] 2021―Jun―15 Clinical Course and Risk Factors for In-Hospital Mortality of 205 Patients with SARS-CoV-2 Pneumonia in Como, Lombardy Region, Italy Mauro Turrini, Angelo Gardellini, Livia Beretta, Lucia Buzzi, Stefano Ferrario, Sabrina Vasile, et al. (+10)
69 [GO] 2021―Jun―15 A Murine CD8+ T Cell Epitope Identified in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein Jihyun Yang, Eunjin Kim, Jong-Soo Lee, Haryoung Poo
70 [GO] 2021―Jun―11 Knowledge and Acceptance of COVID-19 Vaccination among Undergraduate Students from Central and Southern Italy Francesca Gallè, Elita Anna Sabella, Paolo Roma, Osvalda De Giglio, Giuseppina Caggiano, Silvio Tafuri, et al. (+6)
71 [GO] 2021―Jun―11 COVID-19 Vaccination in Patients with Classic Kaposi’s Sarcoma Alice Indini, Athanasia Tourlaki, Francesco Grossi, Donatella Gambini, Lucia Brambilla
72 [GO] 2021―Jun―11 Specific Treatment Exists for SARS-CoV-2 ARDS Badar Kanwar, Chul Joong Lee, Jong-Hoon Lee
73 [GO] 2021―Jun―11 SARS-CoV-2 Genetic Variability and Non-Specific Immunity Associated with the Use of Different BCG Strains-A Molecular and Clinical Approach Jakub Kulus, Magdalena Kulus, Katarzyna Stefańska, Jarosław Sobolewski, Hanna Piotrowska-Kempisty, Paul Mozdziak, Bartosz Kempisty
74 [GO] 2021―Jun―11 Factors Influencing SARS-CoV-2 Vaccine Acceptance and Hesitancy in a Population-Based Sample in Italy Marco Del Riccio, Sara Boccalini, Lisa Rigon, Massimiliano Alberto Biamonte, Giuseppe Albora, Duccio Giorgetti, et al. (+2)
75 [GO] 2021―Jun―10 Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: Data from an Italian Province Maria Elena Flacco, Graziella Soldato, Cecilia Acuti Martellucci, Roberto Carota, Rossano Di Luzio, Antonio Caponetti, Lamberto Manzoli
76 [GO] 2021―Jun―10 A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals Vivek P Chavda, Jack Feehan, Vasso Apostolopoulos
77 [GO] 2021―Jun―09 A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel Neta Zuckerman, Shay Fleishon, Efrat Bucris, Dana Bar-Ilan, Michal Linial, Itay Bar-Or, et al. (+7)
78 [GO] 2021―Jun―09 A Quantitative Benefit-Risk Analysis of ChAdOx1 nCoV-19 Vaccine among People under 60 in Italy Raffaele Palladino, Daniele Ceriotti, Damiano De Ambrosi, Marta De Vito, Marco Farsoni, Giuseppina Seminara, Francesco Barone-Adesi
79 [GO] 2021―Jun―09 Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination Vincenzo Puro, Concetta Castilletti, Chiara Agrati, Delia Goletti, Sara Leone, Alessandro Agresta, et al. (+13)
80 [GO] 2021―Jun―09 Seroprevalence of SARS-CoV-2 Antibodies in Symptomatic Individuals Is Higher than in Persons Who Are at Increased Risk Exposure: The Results of the Single-Center, Prospective, Cross-Sectional Study Alexandr Zurochka, Maria Dobrinina, Vladimir Zurochka, Desheng Hu, Alexandr Solovyev, Liana Ryabova, et al. (+3)
81 [GO] 2021―Jun―08 Perception of Health, Mistrust, Anxiety, and Indecision in a Group of Italians Vaccinated against COVID-19 Giuseppina Moccia, Luna Carpinelli, Giulia Savarese, Anna Borrelli, Giovanni Boccia, Oriana Motta, et al. (+2)
82 [GO] 2021―Jun―08 Characterization of Immune Responses to SARS-CoV-2 and Other Human Pathogenic Coronaviruses Using a Multiplex Bead-Based Immunoassay Wegene Borena, Janine Kimpel, Melanie Gierer, Annika Rössler, Lydia Riepler, Susanne Oehler, et al. (+2)
83 [GO] 2021―Jun―07 Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Govindasamy Agoramoorthy, Sang-Soo Lee
84 [GO] 2021―Jun―07 Knowledge, Attitudes, and Practices (KAP) toward the COVID-19 Vaccine in Oman: A Pre-Campaign Cross-Sectional Study Sabria Al-Marshoudi, Haleema Al-Balushi, Adil Al-Wahaibi, Sulien Al-Khalili, Amal Al-Maani, Noura Al-Farsi, et al. (+9)
85 [GO] 2021―Jun―07 The Many Faces of Innate Immunity in SARS-CoV-2 Infection Nicholas Hanan, Ronnie L. Doud, In-Woo Park, Harlan P. Jones, Stephen O. Mathew
86 [GO] 2021―Jun―04 Could a New COVID-19 Mutant Strain Undermine Vaccination Efforts? A Mathematical Modelling Approach for Estimating the Spread of B.1.1.7 Using Ontario, Canada, as a Case Study Mattew Betti, Nicola Bragazzi, Jane Heffernan, Jude Kong, Angie Raad
87 [GO] 2021―Jun―04 Lack of Trust, Conspiracy Beliefs, and Social Media Use Predict COVID-19 Vaccine Hesitancy Will Jennings, Gerry Stoker, Hannah Bunting, Viktor Orri Valgarðsson, Jennifer Gaskell, Daniel Devine, et al. (+2)
88 [GO] 2021―Jun―04 Comparison of Primary Virus Isolation in Pulmonary Alveolar Macrophages and Four Different Continuous Cell Lines for Type 1 and Type 2 Porcine Reproductive and Respiratory Syndrome Virus Jiexiong Xie, Nick Vereecke, Sebastiaan Theuns, Dayoung Oh, Nathalie Vanderheijden, Ivan Trus, et al. (+7)
89 [GO] 2021―Jun―03 Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination Jodi F. Hedges, Macy A. Thompson, Deann T. Snyder, Amanda Robison, Matthew P. Taylor, Mark A. Jutila
90 [GO] 2021―Jun―03 Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans Sicong Yu, Keda Chen, Lei Fang, Haiyan Mao, Xiuyu Lou, Chaonan Li, Yanjun Zhang
91 [GO] 2021―Jun―03 Outbreak of SARS-CoV-2 Lineage 20I/501Y.V1 in a Nursing Home Underlines the Crucial Role of Vaccination in Both Residents and Staff Andrea Orsi, Alexander Domnich, Vanessa De Pace, Valentina Ricucci, Patrizia Caligiuri, Livio Bottiglieri, et al. (+5)
92 [GO] 2021―Jun―02 Challenges and Opportunities of Mass Vaccination Centers in COVID-19 Times: A Rapid Review of Literature Vincenza Gianfredi, Flavia Pennisi, Alessandra Lume, Giovanni Emanuele Ricciardi, Massimo Minerva, Matteo Riccò, et al. (+2)
93 [GO] 2021―Jun―02 Pancreatic Injury after COVID-19 Vaccine-A Case Report Artur Cieślewicz, Magdalena Dudek, Iwona Krela-Kaźmierczak, Anna Jabłecka, Maciej Lesiak, Katarzyna Korzeniowska
94 [GO] 2021―Jun―02 Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines Osama Abu-Hammad, Hamza Alduraidi, Shaden Abu-Hammad, Ahmed Alnazzawi, Hamzah Babkair, Abdalla Abu-Hammad, et al. (+3)
95 [GO] 2021―Jun―02 Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis Haoyue Cheng, Zhicheng Peng, Wenliang Luo, Shuting Si, Minjia Mo, Haibo Zhou, et al. (+3)
96 [GO] 2021―Jun―02 What Prompts Doctors to Recommend COVID-19 Vaccines: Is It a Question of Positive Emotion? Venerando Rapisarda, Francesca Vella, Caterina Ledda, Massimiliano Barattucci, Tiziana Ramaci
97 [GO] 2021―Jun―02 Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2 Mina Psichogiou, Michael Samarkos, Nikolaos Mikos, Angelos Hatzakis
98 [GO] 2021―Jun―02 An Immunoinformatics Approach for SARS-CoV-2 in Latam Populations and Multi-Epitope Vaccine Candidate Directed towards the World’s Population Andrés Felipe Cuspoca, Laura Lorena Díaz, Alvaro Fernando Acosta, Marcela Katherine Peñaloza, Yardany Rafael Méndez, Diana Carolina Clavijo, Juvenal Yosa Reyes
99 [GO] 2021―May―31 Global Prevalence and Drivers of Dental Students’ COVID-19 Vaccine Hesitancy Abanoub Riad, Huthaifa Abdulqader, Mariana Morgado, Silvi Domnori, Michal Koščík, José João Mendes, et al. (+2)
100 [GO] 2021―May―31 Lymphopenia in COVID-19: γδ T Cells-Based Therapeutic Opportunities Elena Lo Presti, Francesco Dieli, Serena Meraviglia
101 [GO] 2021―May―28 Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism Piotr Rzymski, Bartłomiej Perek, Robert Flisiak
102 [GO] 2021―May―28 SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center Luciana Kase Tanno, Frédéric Berard, Etienne Beaudoin, Alain Didier, Pascal Demoly
103 [GO] 2021―May―27 The Relevance of Monoclonal Antibodies in the Treatment of COVID-19 Anabel Torrente-López, Jesús Hermosilla, Natalia Navas, Luis Cuadros-Rodríguez, José Cabeza, Antonio Salmerón-García
104 [GO] 2021―May―27 Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin N. Olaimat, Malik Hatmal, Dina M. Alhaj-Qasem, Tamadur M. Olaimat, Rohimah Mohamud
105 [GO] 2021―May―27 Production of SARS-CoV-2 Virus-Like Particles in Insect Cells Youjun Mi, Tao Xie, Bingdong Zhu, Jiying Tan, Xuefeng Li, Yanping Luo, et al. (+5)
106 [GO] 2021―May―26 Pfizer-BioNTech COVID-19 Vaccine Tolerance in Allergic versus Non-Allergic Individuals Marita Nittner-Marszalska, Marta Rosiek-Biegus, Agnieszka Kopeć, Robert Pawłowicz, Magdalena Kosińska, Aleksandra Łata, Leszek Szenborn
107 [GO] 2021―May―25 Factors Influencing Public Attitudes towards COVID-19 Vaccination: A Scoping Review Informed by the Socio-Ecological Model Ghadir Fakhri Al-Jayyousi, Mohamed Abdelhady Mabrouk Sherbash, Lamees Abdullah Mohammed Ali, Asmaa El-Heneidy, Nour Waleed Zuhair Alhussaini, Manar Elsheikh Abdelrahman Elhassan, Maisa Ayman Nazzal
108 [GO] 2021―May―25 Population (Antibody) Testing for COVID-19-Technical Challenges, Application and Relevance, an English Perspective Peter A. C. Maple
109 [GO] 2021―May―24 COVID-19 Pandemic and Equal Access to Vaccines Matteo Bolcato, Daniele Rodriguez, Alessandro Feola, Giulio Di Mizio, Alessandro Bonsignore, Rosagemma Ciliberti, et al. (+3)
110 [GO] 2021―May―24 COVID-19 Vaccine Acceptability and Adherence to Preventive Measures in Somalia: Results of an Online Survey Mohammed A. M. Ahmed, Robert Colebunders, Abdi A. Gele, Abdiqani A. Farah, Shariff Osman, Ibraahim Abdullahi Guled, et al. (+4)
111 [GO] 2021―May―24 Maximization of Open Hospital Capacity under Shortage of SARS-CoV-2 Vaccines-An Open Access, Stochastic Simulation Tool Wolfram A. Bosbach, Martin Heinrich, Rainer Kolisch, Christian Heiss
112 [GO] 2021―May―24 Prevalence of Anti-SARS-CoV-2 Antibodies in Poznań, Poland, after the First Wave of the COVID-19 Pandemic Dagny Lorent, Rafal Nowak, Carolina Roxo, Elzbieta Lenartowicz, Aleksandra Makarewicz, Bartosz Zaremba, et al. (+5)
113 [GO] 2021―May―24 Hesitancy towards COVID-19 Vaccination among Healthcare Workers: A Multi-Centric Survey in France Cécile Janssen, Alexis Maillard, Céline Bodelet, Anne-Laure Claudel, Jacques Gaillat, Tristan Delory
114 [GO] 2021―May―20 Delivery Routes for COVID-19 Vaccines Jang Hyun Park, Heung Kyu Lee
115 [GO] 2021―May―20 The Association between Influenza Vaccination and COVID-19 and Its Outcomes: A Systematic Review and Meta-Analysis of Observational Studies Ruitong Wang, Min Liu, Jue Liu
116 [GO] 2021―May―20 Comparisons of Motivation to Receive COVID-19 Vaccination and Related Factors between Frontline Physicians and Nurses and the Public in Taiwan: Applying the Extended Protection Motivation Theory Yen-Ju Lin, Cheng-Fang Yen, Yu-Ping Chang, Peng-Wei Wang
117 [GO] 2021―May―19 The Gender Impact Assessment among Healthcare Workers in the SARS-CoV-2 Vaccination-An Analysis of Serological Response and Side Effects Chiara Di Di Resta, Davide Ferrari, Marco Viganò, Matteo Moro, Eleonora Sabetta, Massimo Minerva, et al. (+3)
118 [GO] 2021―May―19 A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques Paul E. Harris, Trevor Brasel, Christopher Massey, C. V. Herst, Scott Burkholz, Peter Lloyd, et al. (+8)
119 [GO] 2021―May―18 Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants Gabriele Anichini, Chiara Terrosi, Gianni Gori Savellini, Claudia Gandolfo, Federico Franchi, Maria Grazia Cusi
120 [GO] 2021―May―17 Knowledge, Attitudes and Perceptions of COVID-19 Vaccination among Healthcare Workers of an Inner-City Hospital in New York Federico Ciardi, Vidya Menon, Jamie L. Jensen, Masood A Shariff, Anjana Pillai, Usha Venugopal, et al. (+4)
121 [GO] 2021―May―17 Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries Suzanna Awang Bono, Edlaine Faria de Moura Villela, Ching Sin Siau, Won Sun Chen, Supa Pengpid, M Tasdik Hasan, et al. (+8)
122 [GO] 2021―May―17 COVID-19 Vaccine: A Survey of Hesitancy in Patients with Celiac Disease Andrea Costantino, Matilde Topa, Leda Roncoroni, Luisa Doneda, Vincenza Lombardo, Davide Stocco, et al. (+4)
123 [GO] 2021―May―17 Accidental Interruption of the Cold Chain for the Preservation of the Moderna COVID-19 Vaccine Santiago Grau, Olivia Ferrández, Elena Martín-García, Rafael Maldonado
124 [GO] 2021―May―14 Attitudes toward Vaccination against COVID-19 in Poland. A Longitudinal Study Performed before and Two Months after the Commencement of the Population Vaccination Programme in Poland Mateusz Babicki, Agnieszka Mastalerz-Migas
125 [GO] 2021―May―14 Repeated Leftover Serosurvey of SARS-CoV-2 IgG Antibodies in Greece, May to August 2020 Zacharoula Bogogiannidou, Matthaios Speletas, Alexandros Vontas, Dimitrios J. Nikoulis, Katerina Dadouli, Maria A. Kyritsi, et al. (+19)
126 [GO] 2021―May―13 The Incidence and Severity of Post-Vaccination Reactions after Vaccination against COVID-19 Izabela Jęśkowiak, Benita Wiatrak, Patrycja Grosman-Dziewiszek, Adam Szeląg
127 [GO] 2021―May―13 Intention to Be Vaccinated for COVID-19 among Italian Nurses during the Pandemic Marco Trabucco Aurilio, Francesco Saverio Mennini, Simone Gazzillo, Laura Massini, Matteo Bolcato, Alessandro Feola, et al. (+2)
128 [GO] 2021―May―13 Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2 Chotiwat Seephetdee, Nattawut Buasri, Kanit Bhukhai, Kitima Srisanga, Suwimon Manopwisedjaroen, Sarat Lertjintanakit, et al. (+10)
129 [GO] 2021―May―12 Will COVID-19 Vaccinations End Discrimination against COVID-19 Patients in China? New Evidence on Recovered COVID-19 Patients Lu Li, Jian Wang, Anli Leng, Stephen Nicholas, Elizabeth Maitland, Rugang Liu
130 [GO] 2021―May―12 Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity James E. K. Hildreth, Donald J. Alcendor
131 [GO] 2021―May―11 Immune Response to COVID-19 mRNA Vaccine-A Pilot Study Andrzej Lange, Agata Borowik, Jolanta Bocheńska, Joanna Rossowska, Emilia Jaskuła
132 [GO] 2021―May―10 Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19 Tatiana Mina Yendo, Maria Notomi Sato, Anna Cláudia Calvielli Castelo Branco, Anna Julia Pietrobon, Franciane Mouradian Emidio Teixeira, Yasmim Álefe Leuzzi Ramos, et al. (+9)
133 [GO] 2021―May―10 Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths Robert Root-Bernstein
134 [GO] 2021―May―10 Willingness to Vaccinate against COVID-19 Declines in Australia, Except in Lockdown Areas Quyen G. To, Robert Stanton, Saman Khalesi, Susan L. Williams, Stephanie J. Alley, Tanya L. Thwaite, et al. (+2)
135 [GO] 2021―May―10 A Comparison of the Level of Acceptance and Hesitancy towards the Influenza Vaccine and the Forthcoming COVID-19 Vaccine in the Medical Community Magdalena Grochowska, Aleksandra Ratajczak, Gabriela Zdunek, Aleksander Adamiec, Paweł Waszkiewicz, Wojciech Feleszko
136 [GO] 2021―May―10 What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments Dominik Wawrzuta, Mariusz Jaworski, Joanna Gotlib, Mariusz Panczyk
137 [GO] 2021―May―10 Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model Rémi Vernet, Emily Charrier, Erika Cosset, Sabine Fièvre, Ugo Tomasello, Julien Grogg, Nicolas Mach
138 [GO] 2021―May―10 Porcine Reproductive and Respiratory Syndrome Virus: Immune Escape and Application of Reverse Genetics in Attenuated Live Vaccine Development Honglei Wang, Yangyang Xu, Wenhai Feng
139 [GO] 2021―May―08 Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease Sedigheh Taghinezhad-S, Amir Hossein Mohseni, Luis G. Bermúdez-Humarán, Vincenzo Casolaro, Naima G. Cortes-Perez, Hossein Keyvani, Jesus Simal-Gandara
140 [GO] 2021―May―08 Attitudes towards COVID-19 Vaccination among Hospital Staff-Understanding What Matters to Hesitant People Anne Spinewine, Catherine Pétein, Perrine Evrard, Christelle Vastrade, Christine Laurent, Bénédicte Delaere, Séverine Henrard
141 [GO] 2021―May―08 Sensitivity to COVID-19 Vaccine Effectiveness and Safety in Shanghai, China Jia Lu, Xiaosa Wen, Qi Guo, Mengdi Ji, Felicia Zhang, Abram L. Wagner, Yihan Lu
142 [GO] 2021―May―08 Prevalence and Potential Determinants of COVID-19 Vaccine Hesitancy and Resistance in Qatar: Results from a Nationally Representative Survey of Qatari Nationals and Migrants between December 2020 and January 2021 Salma M. Khaled, Catalina Petcu, Lina Bader, Iman Amro, Aisha Mohammed H. A. Al-Hamadi, Marwa Al Assi, et al. (+8)
143 [GO] 2021―May―08 Healthcare Workers’ Perspectives on the Upcoming COVID-19 Vaccine in Terms of Their Exposure to the Influenza Vaccine in Riyadh, Saudi Arabia: A Cross-Sectional Study Leena R. Baghdadi, Shatha G. Alghaihb, Alanoud A. Abuhaimed, Dania M. Alkelabi, Rawan S. Alqahtani
144 [GO] 2021―May―08 Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials Ali Pormohammad, Mohammad Zarei, Saied Ghorbani, Mehdi Mohammadi, Mohammad Hossein Razizadeh, Diana L. Turner, Raymond J. Turner
145 [GO] 2021―May―06 Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2 Aline Baldo, Amaya Leunda, Nicolas Willemarck, Katia Pauwels
146 [GO] 2021―May―06 Rotavirus as an Expression Platform of Domains of the SARS-CoV-2 Spike Protein Asha Ann Philip, John Thomas Patton
147 [GO] 2021―May―06 Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey Federica Guaraldi, Marco Montalti, Zeno Di Valerio, Edoardo Mannucci, Besmir Nreu, Matteo Monami, Davide Gori
148 [GO] 2021―May―06 Better Pandemic Influenza Preparedness through Adjuvant Technology Transfer: Challenges and Lessons Learned Céline H. Lemoine, Reviany V. Nidom, Roland Ventura, Setyarina Indrasari, Irine Normalina, Kuncoro Puguh Santoso, et al. (+5)
149 [GO] 2021―May―06 Targeted Vaccine Allocation Could Increase the COVID-19 Vaccine Benefits Amidst Its Lack of Availability: A Mathematical Modeling Study in Indonesia Ahmad Fuady, Nuning Nuraini, Kamal K. Sukandar, Bony W. Lestari
150 [GO] 2021―May―02 Hesitancy of Arab Healthcare Workers towards COVID-19 Vaccination: A Large-Scale Multinational Study Eyad Qunaibi, Iman Basheti, Mohamed Soudy, Iyad Sultan
151 [GO] 2021―May―02 Confidence, Acceptance and Willingness to Pay for the COVID-19 Vaccine among Migrants in Shanghai, China: A Cross-Sectional Study Kaiyi Han, Mark R. Francis, Ruiyun Zhang, Qian Wang, Aichen Xia, Linyao Lu, et al. (+2)
152 [GO] 2021―May―02 The Intention to Receive the COVID-19 Vaccine in China: Insights from Protection Motivation Theory Lu Li, Jian Wang, Stephen Nicholas, Elizabeth Maitland, Anli Leng, Rugang Liu
153 [GO] 2021―Apr―29 Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm Ali A. Rabaan, Shamsah H. Al-Ahmed, Javed Muhammad, Amjad Khan, Anupam A Sule, Raghavendra Tirupathi, et al. (+13)
154 [GO] 2021―Apr―29 Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination Abdulla Watad, Gabriele De Marco, Hussein Mahajna, Amit Druyan, Mailam Eltity, Nizar Hijazi, et al. (+20)
155 [GO] 2021―Apr―28 Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities-An Agent-Based Modeling Evaluation Beate Jahn, Gaby Sroczynski, Martin Bicher, Claire Rippinger, Nikolai Mühlberger, Júlia Santamaria, et al. (+16)
156 [GO] 2021―Apr―28 An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times Cielo García-Montero, Oscar Fraile-Martínez, Coral Bravo, Diego Torres-Carranza, Lara Sanchez-Trujillo, Ana M. Gómez-Lahoz, et al. (+10)
157 [GO] 2021―Apr―27 A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response Duško Lainšček, Tina Fink, Vida Forstnerič, Iva Hafner-Bratkovič, Sara Orehek, Žiga Strmšek, et al. (+22)
158 [GO] 2021―Apr―25 Influenza Vaccination and COVID-19 Mortality in the USA: An Ecological Study Claudio Zanettini, Mohamed Omar, Wikum Dinalankara, Eddie Luidy Imada, Elizabeth Colantuoni, Giovanni Parmigiani, Luigi Marchionni
159 [GO] 2021―Apr―25 Off-Label Use of COVID-19 Vaccines from Ethical Issues to Medico-Legal Aspects: An Italian Perspective Davide Ferorelli, Lorenzo Spagnolo, Maricla Marrone, Serena Corradi, Maria Silvestre, Federica Misceo, et al. (+5)
160 [GO] 2021―Apr―25 Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups Hans-Georg Rammensee, Cécile Gouttefangeas, Sonja Heidu, Reinhild Klein, Beate Preuß, Juliane Walz, et al. (+11)
161 [GO] 2021―Apr―25 Acceptance of COVID-19 Vaccination among Front-Line Health Care Workers: A Nationwide Survey of Emergency Medical Services Personnel from Germany André Nohl, Christian Afflerbach, Christian Lurz, Bastian Brune, Tobias Ohmann, Veronika Weichert, et al. (+2)
162 [GO] 2021―Apr―23 #Scamdemic, #Plandemic, or #Scaredemic: What Parler Social Media Platform Tells Us about COVID-19 Vaccine Annalise Baines, Muhammad Ittefaq, Mauryne Abwao
163 [GO] 2021―Apr―22 COVID-19 Vaccination Intent and Willingness to Pay in Bangladesh: A Cross-Sectional Study Russell Kabir, Ilias Mahmud, Mohammad Tawfique Hossain Chowdhury, Divya Vinnakota, Shah Saif Jahan, Nazeeba Siddika, et al. (+3)
164 [GO] 2021―Apr―22 Challenge of Naïve and Vaccinated Pigs with a Vaccine-Derived Recombinant Porcine Reproductive and Respiratory Syndrome Virus 1 Strain (Horsens Strain) Lise K. Kvisgaard, Lars E. Larsen, Charlotte S. Kristensen, Frédéric Paboeuf, Patricia Renson, Olivier Bourry
165 [GO] 2021―Apr―22 Attitudes of Patients with Cancer towards Vaccinations-Results of Online Survey with Special Focus on the Vaccination against COVID-19 Anna Brodziak, Dawid Sigorski, Małgorzata Osmola, Michał Wilk, Angelika Gawlik-Urban, Joanna Kiszka, et al. (+2)
166 [GO] 2021―Apr―22 Association between Influenza Vaccination and Positive SARS-CoV-2 IgG and IgM Tests in the General Population of Katowice Region, Poland Małgorzata Kowalska, Ewa Niewiadomska, Kamil Barański, Angelina Kaleta-Pilarska, Grzegorz Brożek, Jan Eugeniusz Zejda
167 [GO] 2021―Apr―22 Allergy to Polyethilenglicole of Anti-SARS CoV2 Vaccine Recipient: A Case Report of Young Adult Recipient and the Management of Future Exposure to SARS-CoV2 Vincenzo Restivo, Giuseppina Candore, Maria Barrale, Ester Caravello, Giorgio Graziano, Rosa Onida, et al. (+3)
168 [GO] 2021―Apr―22 Correlation of Neutralizing Antibodies (NAbs) between Sows and Piglets and Evaluation of Protectability Associated with Maternally Derived NAbs in Pigs against Circulating Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) under Field Conditions Fu-Chun Hsueh, Sheng-Yuan Wang, Wei-Hao Lin, Chuen-Fu Lin, Chen-Yu Tsai, Chin-Wen Huang, et al. (+3)
169 [GO] 2021―Apr―20 Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database Mansour Tobaiqy, Hajer Elkout, Katie MacLure
170 [GO] 2021―Apr―20 COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey Arnold Hagens, Ahmet Çağkan İnkaya, Kasirga Yildirak, Mesut Sancar, Jurjen van der Schans, Aylin Acar Sancar, et al. (+3)
171 [GO] 2021―Apr―20 AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate Xuelan Liu, Xinyue Chang, Dominik Rothen, Mariliza Derveni, Pascal Krenger, Salony Roongta, et al. (+5)
172 [GO] 2021―Apr―20 Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles Lisha Zha, Xinyue Chang, Hongxin Zhao, Mona O. Mohsen, Liang Hong, Yuhang Zhou, et al. (+9)
173 [GO] 2021―Apr―20 Phenotypic and Genetic Evolutions of a Porcine Reproductive and Respiratory Syndrome Modified Live Vaccine after Limited Passages in Pigs Julie Eclercy, Patricia Renson, Edouard Hirchaud, Mathieu Andraud, Véronique Beven, Frédéric Paboeuf, et al. (+3)
174 [GO] 2021―Apr―20 Analysis of the Feasibility of a Vaccination Campaign against Influenza Epidemic and COVID-19 Pandemic in French Emergency Departments: A National Survey Daniel Aiham Ghazali, Christophe Choquet, Donia Bouzid, Luisa Colosi, Arsalene Ben Hammouda, Mathias Wargon, et al. (+7)
175 [GO] 2021―Apr―16 COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns Mohamed Joma, Claire-Maelle Fovet, Nabila Seddiki, Pierre Gressens, Mireille Laforge
176 [GO] 2021―Apr―16 A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay Gaetano Donofrio, Valentina Franceschi, Francesca Macchi, Luca Russo, Anna Rocci, Valentina Marchica, et al. (+4)
177 [GO] 2021―Apr―15 Modeling of Vaccination and Contact Tracing as Tools to Control the COVID-19 Outbreak in Spain Mª Àngels Colomer, Antoni Margalida, Francesc Alòs, Pilar Oliva-Vidal, Anna Vilella, Lorenzo Fraile
178 [GO] 2021―Apr―14 The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland Piotr Rzymski, Joanna Zeyland, Barbara Poniedziałek, Ilona Małecka, Jacek Wysocki
179 [GO] 2021―Apr―13 Intention to Get COVID-19 Vaccinations among Ophthalmology Residents in Poland: A Cross-Sectional Survey Joanna Konopińska, Iwona Obuchowska, Łukasz Lisowski, Natalia Dub, Milena Kozera, Marek Rękas
180 [GO] 2021―Apr―13 Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST) Madhusudhanan Narasimhan, Lenin Mahimainathan, Ellen Araj, Andrew E Clark, Kathleen Wilkinson, Sruthi Yekkaluri, et al. (+6)
181 [GO] 2021―Apr―13 Would Parents Get Their Children Vaccinated Against SARS-CoV-2? Rate and Predictors of Vaccine Hesitancy According to a Survey over 5000 Families from Bologna, Italy Marco Montalti, Flavia Rallo, Federica Guaraldi, Lapo Bartoli, Giulia Po, Michela Stillo, et al. (+8)
182 [GO] 2021―Apr―13 Porcine Reproductive and Respiratory Syndrome Modified Live Virus Vaccine: A “Leaky” Vaccine with Debatable Efficacy and Safety Lei Zhou, Xinna Ge, Hanchun Yang
183 [GO] 2021―Apr―13 Motivation to Have COVID-19 Vaccination Explained Using an Extended Protection Motivation Theory among University Students in China: The Role of Information Sources Peng-Wei Wang, Daniel Kwasi Ahorsu, Chung-Ying Lin, I-Hua Chen, Cheng-Fang Yen, Yi-Jie Kuo, et al. (+2)
184 [GO] 2021―Apr―13 Effect of Information about COVID-19 Vaccine Effectiveness and Side Effects on Behavioural Intentions: Two Online Experiments John R. Kerr, Alexandra L. J. Freeman, Theresa M. Marteau, Sander van der Linden
185 [GO] 2021―Apr―13 Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy Chiara Reno, Elisa Maietti, Maria Pia Fantini, Elena Savoia, Lamberto Manzoli, Marco Montalti, Davide Gori
186 [GO] 2021―Apr―09 Influenza Vaccination and Health Outcomes in COVID-19 Patients: A Retrospective Cohort Study Pasquale Domenico Pedote, Stefano Termite, Andrea Gigliobianco, Pier Luigi Lopalco, Francesco Paolo Bianchi
187 [GO] 2021―Apr―09 Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines Thai Thanh Hoang Thi, Estelle J. A. Suys, Jung Seok Lee, Dai Hai Nguyen, Ki Dong Park, Nghia P. Truong
188 [GO] 2021―Apr―09 Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis Michael Jahn, Johannes Korth, Oliver Dorsch, Olympia Evdoxia Anastasiou, Burkhard Sorge-Hädicke, Bartosz Tyczynski, et al. (+6)
189 [GO] 2021―Apr―05 COVID-19’s Impact on Willingness to Be Vaccinated against Influenza and COVID-19 during the 2020/2021 Season: Results from an Online Survey of Canadian Adults 50 Years and Older Nancy M. Waite, Jennifer A. Pereira, Sherilyn K. D. Houle, Vladimir Gilca, Melissa K. Andrew
190 [GO] 2021―Apr―05 The COVID-19 Vaccines: Recent Development, Challenges and Prospects Yuxin Yan, Yoongxin Pang, Zhuoyi Lyu, Ruiqi Wang, Xinyun Wu, Chong You, et al. (+5)
191 [GO] 2021―Apr―01 BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19 Rui-Ru Ji, Yajin Qu, Hua Zhu, Yumei Yang, Annette B. Vogel, Ugur Sahin, et al. (+2)
192 [GO] 2021―Apr―01 Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing William Douglas Evans, Jeff French
193 [GO] 2021―Apr―01 Willingness to Pay for a Hypothetical COVID-19 Vaccine in the United States: A Contingent Valuation Approach Serkan Catma, Serkan Varol
194 [GO] 2021―Apr―01 Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks Jesse O’Shea, Mark R. Prausnitz, Nadine Rouphael
195 [GO] 2021―Apr―01 COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study Dalia Almaghaslah, Abdulrhman Alsayari, Geetha Kandasamy, Rajalakshimi Vasudevan
196 [GO] 2021―Apr―01 The COVID-19 Vaccine Is Here-Now Who Is Willing to Get It? William D. S. Killgore, Sara A. Cloonan, Emily C. Taylor, Natalie S. Dailey
197 [GO] 2021―Apr―01 The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines Tasnim Hasan, Justin Beardsley, Ben J. Marais, Thu Anh Nguyen, Greg J. Fox
198 [GO] 2021―Apr―01 Vaccine Hesitancy: COVID-19 and Influenza Vaccine Willingness among Parents in Wuxi, China-A Cross-Sectional Study Qiang Wang, Shixin Xiu, Shuangyu Zhao, Jianli Wang, Ying Han, Shuheng Dong, et al. (+12)
199 [GO] 2021―Apr―01 A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model Izabela K Ragan, Lindsay M Hartson, Taru S Dutt, Andres Obregon-Henao, Rachel M Maison, Paul Gordy, et al. (+10)
200 [GO] 2021―Apr―01 Factors Influencing the Efficacy of COVID-19 Vaccines: A Quantitative Synthesis of Phase III Trials Luigino Calzetta, Beatrice Ludovica Ritondo, Angelo Coppola, Maria Gabriella Matera, Nicola Di Daniele, Paola Rogliani
201 [GO] 2021―Mar―29 Reasons for Taking the COVID-19 Vaccine by US Social Media Users Arriel Benis, Abraham Seidmann, Shai Ashkenazi
202 [GO] 2021―Mar―29 Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice Ki-Hye Kim, Noopur Bhatnagar, Subbiah Jeeva, Judy Oh, Bo Ryoung Park, Chong Hyun Shin, et al. (+2)
203 [GO] 2021―Mar―25 Soluble Spike DNA Vaccine Provides Long-Term Protective Immunity against SARS-CoV-2 in Mice and Nonhuman Primates Yong Bok Seo, You Suk Suh, Ji In Ryu, Hwanhee Jang, Hanseul Oh, Bon-Sang Koo, et al. (+5)
204 [GO] 2021―Mar―24 COVID-19 Vaccine Hesitancy among French People Living with HIV Alexandre Vallée, Erwan Fourn, Catherine Majerholc, Pauline Touche, David Zucman
205 [GO] 2021―Mar―22 Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19 Jiao Tong, Chenxi Zhu, Hanyu Lai, Chunchao Feng, Dapeng Zhou
206 [GO] 2021―Mar―22 Measurement Invariance of the Drivers of COVID-19 Vaccination Acceptance Scale: Comparison between Taiwanese and Mainland Chinese-Speaking Populations Ya-Chin Yeh, I-Hua Chen, Daniel K. Ahorsu, Nai-Ying Ko, Kuan-Lin Chen, Ping-Chia Li, et al. (+4)
207 [GO] 2021―Mar―22 Factors Associated with COVID-19 Vaccine Hesitancy Patricia Soares, João Victor Rocha, Marta Moniz, Ana Gama, Pedro Almeida Laires, Ana Rita Pedro, et al. (+3)
208 [GO] 2021―Mar―22 Phylogenomic Evidence of Reinfection and Persistence of SARS-CoV-2: First Report from Colombia Juan David Ramírez, Marina Muñoz, Nathalia Ballesteros, Luz H. Patiño, Sergio Castañeda, Carlos A. Rincón, et al. (+8)
209 [GO] 2021―Mar―22 Perception of COVID-19 Vaccination Amongst Physicians in Colombia Jorge L. Alvarado-Socarras, Andrea Liliana Vesga-Varela, Doris Cristina Quintero-Lesmes, Marcela M. Fama-Pereira, Norma C. Serrano-Diaz, Mauricio Vasco, et al. (+4)
210 [GO] 2021―Mar―22 COVID-19 Vaccination Willingness among Chinese Adults under the Free Vaccination Policy Rugang Liu, Yuxun Zhang, Stephen Nicholas, Anli Leng, Elizabeth Maitland, Jian Wang
211 [GO] 2021―Mar―19 Is COVID-19 a Real Incentive for Flu Vaccination? Let the Numbers Speak for Themselves Marcello Di Pumpo, Giuseppe Vetrugno, Domenico Pascucci, Elettra Carini, Viria Beccia, Anna Sguera, et al. (+7)
212 [GO] 2021―Mar―19 A Commentary on Realities of Developing COVID-19 Vaccines Discussed through the Global Health Safety Perspective Wedad Saeed Al-Qahtani, Fatmah Ahmed Alsafhi
213 [GO] 2021―Mar―19 Exploring the Willingness to Accept SARS-CoV-2 Vaccine in a University Population in Southern Italy, September to November 2020 Gabriella Di Giuseppe, Concetta Paola Pelullo, Giorgia Della Polla, Maria Pavia, Italo Francesco Angelillo
214 [GO] 2021―Mar―18 Italian Adults’ Likelihood of Getting COVID-19 Vaccine: A Second Online Survey Luigi Roberto Biasio, Guglielmo Bonaccorsi, Chiara Lorini, Daniela Mazzini, Sergio Pecorelli
215 [GO] 2021―Mar―15 A Descriptive-Multivariate Analysis of Community Knowledge, Confidence, and Trust in COVID-19 Clinical Trials among Healthcare Workers in Uganda Keneth Iceland Kasozi, Anne Laudisoit, Lawrence Obado Osuwat, Gaber El-Saber Batiha, Naif E. Al Omairi, Eric Aigbogun, et al. (+27)
216 [GO] 2021―Mar―15 Factors Affecting Attitudes towards COVID-19 Vaccination: An Online Survey in Slovenia Luka Petravić, Rok Arh, Tina Gabrovec, Lucija Jazbec, Nika Rupčić, Nina Starešinič, et al. (+5)
217 [GO] 2021―Mar―15 COVID-19 Vaccine Roll-Out in South Africa and Zimbabwe: Urgent Need to Address Community Preparedness, Fears and Hesitancy Tafadzwa Dzinamarira, Brian Nachipo, Bright Phiri, Godfrey Musuka
218 [GO] 2021―Mar―15 How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists Alfredo Papa, Franco Scaldaferri, Lorenzo Maria Vetrone, Matteo Neri, Antonio Gasbarrini, Loris Riccardo Lopetuso
219 [GO] 2021―Mar―12 Willingness of Taiwan’s Healthcare Workers and Outpatients to Vaccinate against COVID-19 during a Period without Community Outbreaks Shikha Kukreti, Mei-Yun Lu, Yi-Hsuan Lin, Carol Strong, Chung-Ying Lin, Nai-Ying Ko, et al. (+2)
220 [GO] 2021―Mar―11 COVID-19 Vaccines in the Pipeline, Are Antibodies Adequate? Md Kamal Hossain, Majid Hassanzadeganroudsari, Jack Feehan, Vasso Apostolopoulos
221 [GO] 2021―Mar―11 Correlates of Vaccine-Induced Protection against SARS-CoV-2 Till Koch, Sibylle C. Mellinghoff, Parichehr Shamsrizi, Marylyn M. Addo, Christine Dahlke
222 [GO] 2021―Mar―11 Simultaneous CD8+ T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs Flavia Ferrantelli, Chiara Chiozzini, Francesco Manfredi, Andrea Giovannelli, Patrizia Leone, Maurizio Federico
223 [GO] 2021―Mar―11 Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19 Carmen Elena Gómez, Beatriz Perdiguero, Mariano Esteban
224 [GO] 2021―Mar―05 Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China Monia Makhoul, Hiam Chemaitelly, Houssein H. Ayoub, Shaheen Seedat, Laith J. Abu-Raddad
225 [GO] 2021―Mar―05 Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations Nicholas G. Kounis, Ioanna Koniari, Cesare de Gregorio, Dimitris Velissaris, Konstantinos Petalas, Aikaterini Brinia, et al. (+6)
226 [GO] 2021―Mar―05 Acceptability of a COVID-19 Vaccine among the Saudi Population Eman Ibrahim Alfageeh, Noor Alshareef, Khadijah Angawi, Fahad Alhazmi, Gowokani Chijere Chirwa
227 [GO] 2021―Mar―05 COVID-19 Vaccine Failure in a Patient with Multiple Sclerosis on Ocrelizumab Sridhar Chilimuri, Nikhitha Mantri, Sudharsan Gongati, Maleeha Zahid, Haozhe Sun
228 [GO] 2021―Mar―05 SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines Paola Rogliani, Alfredo Chetta, Mario Cazzola, Luigino Calzetta
229 [GO] 2021―Mar―05 Attitude and Behaviors towards SARS-CoV-2 Vaccination among Healthcare Workers: A Cross-Sectional Study from Poland Bartosz Szmyd, Filip Franciszek Karuga, Adrian Bartoszek, Katarzyna Staniecka, Natalia Siwecka, Agnieszka Bartoszek, et al. (+2)
230 [GO] 2021―Mar―04 Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies Ahmed Kandeil, Ahmed Mostafa, Rehab R. Hegazy, Rabeh El-Shesheny, Ahmed El Taweel, Mokhtar R. Gomaa, et al. (+21)
231 [GO] 2021―Mar―03 Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic Masaki Machida, Itaru Nakamura, Takako Kojima, Reiko Saito, Tomoki Nakaya, Tomoya Hanibuchi, et al. (+7)
232 [GO] 2021―Mar―03 Heightened Willingness toward Pneumococcal Vaccination in the Elderly Population in Shenzhen, China: A Cross-Sectional Study during the COVID-19 Pandemic Minyi Zhang, Hongbiao Chen, Fei Wu, Qiushuang Li, Qihui Lin, He Cao, et al. (+3)
233 [GO] 2021―Mar―02 SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response Ourania E. Tsitsilonis, Dimitrios Paraskevis, Evi Lianidou, Evangelos Terpos, Athanasios Akalestos, Vassilios Pierros, et al. (+27)
234 [GO] 2021―Mar―02 Reduced Virus Load in Lungs of Pigs Challenged with Porcine Reproductive and Respiratory Syndrome Virus after Vaccination with Virus Replicon Particles Encoding Conserved PRRSV Cytotoxic T-Cell Epitopes Simon Welner, Nicolas Ruggli, Matthias Liniger, Artur Summerfield, Lars Erik Larsen, Gregers Jungersen
235 [GO] 2021―Mar―01 Acceptability of COVID-19 Vaccination among Greek Health Professionals Dimitrios Papagiannis, George Rachiotis, Foteini Malli, Ioanna V. Papathanasiou, Ourania Kotsiou, Evangelos C. Fradelos, et al. (+2)
236 [GO] 2021―Mar―01 Correction: Kis, Z. et al. Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand. Vaccines 2021, 9, 3 Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah
237 [GO] 2021―Mar―01 COVID-19 Vaccine Acceptance among an Online Sample of Sexual and Gender Minority Men and Transgender Women Daniel Teixeira da Silva, Katie Biello, Willey Y. Lin, Pablo K. Valente, Kenneth H. Mayer, Lisa Hightow-Weidman, José A. Bauermeister
238 [GO] 2021―Feb―26 The Changing Acceptance of COVID-19 Vaccination in Different Epidemic Phases in China: A Longitudinal Study Jiahao Wang, Xinran Lu, Xiaozhen Lai, Yun Lyu, Haijun Zhang, Yufei Fenghuang, et al. (+4)
239 [GO] 2021―Feb―26 Who Should Get COVID-19 Vaccine First? A Survey to Evaluate Hospital Workers’ Opinion Lucia Craxì, Alessandra Casuccio, Emanuele Amodio, Vincenzo Restivo
240 [GO] 2021―Feb―26 Development of Pandemic Vaccines: ERVEBO Case Study Jayanthi Wolf, Risat Jannat, Sheri Dubey, Sean Troth, Matthew T. Onorato, Beth-Ann Coller, et al. (+2)
241 [GO] 2021―Feb―20 Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2 Kim Tien Ng, Nur Khairiah Mohd-Ismail, Yee-Joo Tan
242 [GO] 2021―Feb―19 Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination Valentina Gerussi, Maddalena Peghin, Alvisa Palese, Valentina Bressan, Erica Visintini, Giulia Bontempo, et al. (+4)
243 [GO] 2021―Feb―19 Are We Ready for the Arrival of the New COVID-19 Vaccinations? Great Promises and Unknown Challenges Still to Come Davide Gori, Chiara Reno, Daniel Remondini, Francesco Durazzi, Maria Pia Fantini
244 [GO] 2021―Feb―19 Spain’s Hesitation at the Gates of a COVID-19 Vaccine Hans Eguia, Franco Vinciarelli, Marina Bosque-Prous, Troels Kristensen, Francesc Saigí-Rubió
245 [GO] 2021―Feb―19 COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform Muhammad Umer Ashraf, Yeji Kim, Sunil Kumar, Dongyeob Seo, Maryam Ashraf, Yong-Soo Bae
246 [GO] 2021―Feb―19 Assessment of Vaccine Hesitancy to a COVID-19 Vaccine in Cameroonian Adults and Its Global Implication Jerome Nyhalah Dinga, Leontine Kouemou Sinda, Vincent P. K. Titanji
247 [GO] 2021―Feb―17 COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates Malik Sallam
248 [GO] 2021―Feb―14 COVID-19 Vaccine Acceptance in the Democratic Republic of Congo: A Cross-Sectional Survey John D. Ditekemena, Dalau M. Nkamba, Armand Mutwadi ; Hypolite M. Mavoko, Joseph Nelson Siewe Siewe Fodjo, Christophe Luhata, Michael Obimpeh, et al. (+3)
249 [GO] 2021―Feb―12 Construction and Immunogenicity Comparison of Three Virus-Like Particles Carrying Different Combinations of Structural Proteins of Avian Coronavirus Infectious Bronchitis Virus Yu Zhang, Yuan Yuan, Li-Hua Zhang, Dan Zhu, Lu Wang, Lan-Ping Wei, et al. (+8)
250 [GO] 2021―Feb―12 SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond Emily Bettini, Michela Locci
251 [GO] 2021―Feb―10 Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization Shaswath S. Chandrasekar, Yashdeep Phanse, Rachel E. Hildebrand, Mostafa Hanafy, Chia-Wei Wu, Chungyi H. Hansen, et al. (+3)
252 [GO] 2021―Feb―07 Intention to Receive the COVID-19 Vaccination in China: Application of the Diffusion of Innovations Theory and the Moderating Role of Openness to Experience Phoenix Kit-han Mo, Sitong Luo, Suhua Wang, Junfeng Zhao, Guohua Zhang, Lijuan Li, et al. (+3)
253 [GO] 2021―Feb―07 Medical Students and SARS-CoV-2 Vaccination: Attitude and Behaviors Bartosz Szmyd, Adrian Bartoszek, Filip Franciszek Karuga, Katarzyna Staniecka, Maciej Błaszczyk, Maciej Radek
254 [GO] 2021―Feb―05 Why It Is Important to Develop an Effective and Safe Pediatric COVID-19 Vaccine Nicola Principi, Susanna Esposito
255 [GO] 2021―Feb―05 Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study Álvaro Sosa Liprandi, Ezequiel José Zaidel, Ricardo Lopez Santi, John Jairo Araujo, Manuel Alfonso Baños González, Juan Martín Busso, et al. (+13)
256 [GO] 2021―Feb―04 COVID-19 Vaccination: From Interesting Agent to the Patient Anis Daou
257 [GO] 2021―Feb―04 COVID-19 Vaccine Acceptance among Health Care Workers in the United States Rahul Shekhar, Abu Baker Sheikh, Shubhra Upadhyay, Mriganka Singh, Saket Kottewar, Hamza Mir, et al. (+2)
258 [GO] 2021―Feb―02 The Strategies to Support the COVID-19 Vaccination with Evidence-Based Communication and Tackling Misinformation Piotr Rzymski, Leszek Borkowski, Marcin Drąg, Robert Flisiak, Jacek Jemielity, Jacek Krajewski, et al. (+8)
259 [GO] 2021―Jan―29 Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review Jorge Pérez-Galarza, César Prócel, Cristina Cañadas, Diana Aguirre, Ronny Pibaque, Ricardo Bedón, et al. (+3)
260 [GO] 2021―Jan―28 Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies Johann Sellner, Paulus S. Rommer
261 [GO] 2021―Jan―27 COVID-19 Infection and Previous BCG Vaccination Coverage in the Ecuadorian Population Daniel Garzon-Chavez, Jackson Rivas-Condo, Adriana Echeverria, Jhoanna Mozo, Emmanuelle Quentin, Jorge Reyes, Enrique Teran
262 [GO] 2021―Jan―25 Optimising Vaccine Dose in Inoculation against SARS-CoV-2, a Multi-Factor Optimisation Modelling Study to Maximise Vaccine Safety and Efficacy John Benest, Sophie Rhodes, Matthew Quaife, Thomas G. Evans, Richard G. White
263 [GO] 2021―Jan―22 Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate Larisa I. Karpenko, Andrey P. Rudometov, Sergei V. Sharabrin, Dmitry N. Shcherbakov, Mariya B. Borgoyakova, Sergei I. Bazhan, et al. (+10)
264 [GO] 2021―Jan―21 Impact of COVID-19 Pandemic on Flu and COVID-19 Vaccination Intentions among University Students Roberta Pastorino, Leonardo Villani, Marco Mariani, Walter Ricciardi, Guendalina Graffigna, Stefania Boccia
265 [GO] 2021―Jan―21 Change of Willingness to Accept COVID-19 Vaccine and Reasons of Vaccine Hesitancy of Working People at Different Waves of Local Epidemic in Hong Kong, China: Repeated Cross-Sectional Surveys Kailu Wang, Eliza Lai-Yi Wong, Kin-Fai Ho, Annie Wai-Ling Cheung, Peter Sen-Yung Yau, Dong Dong, et al. (+2)
266 [GO] 2021―Jan―21 Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome Iwona Karwaciak, Anna Sałkowska, Kaja Karaś, Jarosław Dastych, Marcin Ratajewski
267 [GO] 2021―Jan―21 Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses Yongping Yang, Wei Shi, Olubukola M. Abiona, Alexandra Nazzari, Adam S. Olia, Li Ou, et al. (+19)
268 [GO] 2021―Jan―21 A Rapid Systematic Review of Public Responses to Health Messages Encouraging Vaccination against Infectious Diseases in a Pandemic or Epidemic Sadie Lawes-Wickwar, Daniela Ghio, Mei Yee Tang, Chris Keyworth, Sabina Stanescu, Juliette Westbrook, et al. (+18)
269 [GO] 2021―Jan―15 Willingness to Receive COVID-19 Vaccination in Japan Takeshi Yoda, Hironobu Katsuyama
270 [GO] 2021―Jan―14 Flattening the Curve of COVID-19 Vaccine Rejection-An International Overview Wojciech Feleszko, Piotr Lewulis, Adam Czarnecki, Paweł Waszkiewicz
271 [GO] 2021―Jan―13 High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries Malik Sallam, Deema Dababseh, Huda Eid, Kholoud Al-Mahzoum, Ayat Al-Haidar, Duaa Taim, et al. (+4)
272 [GO] 2021―Jan―12 A COVID-19 Vaccine: Big Strides Come with Big Challenges Juanita Mellet, Michael S. Pepper
273 [GO] 2021―Jan―12 Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine? Marco Caminati, Gabriella Guarnieri, Gianenrico Senna
274 [GO] 2021―Jan―12 SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines Yuichiro J. Suzuki, Sergiy G. Gychka
275 [GO] 2021―Jan―12 SARS-CoV-2 Epitope Mapping on Microarrays Highlights Strong Immune-Response to N Protein Region Angelo Musicò, Roberto Frigerio, Alessandro Mussida, Luisa Barzon, Alessandro Sinigaglia, Silvia Riccetti, et al. (+6)
276 [GO] 2021―Jan―11 Current State of the First COVID-19 Vaccines Birgit M. Prüβ
277 [GO] 2021―Jan―11 Impact of Recommended Maternal Vaccination Programs on the Clinical Presentation of SARS-CoV-2 Infection: A Prospective Observational Study Maria de la Cruz Conty, Maria Encinas Pardilla, Marta Garcia Sanchez, Laura Gonzalez Rodriguez, Marta Muner-Hernando, Ana Royuela Vicente, et al. (+5)
278 [GO] 2021―Jan―05 Social Patterning and Stability of Intention to Accept a COVID-19 Vaccine in Scotland: Will Those Most at Risk Accept a Vaccine? Lynn Williams, Paul Flowers, Julie McLeod, David Young, Lesley Rollins
279 [GO] 2021―Jan―05 SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges Ahead Vincenzo Baldo, Chiara Reno, Silvia Cocchio, Maria Pia Fantini
280 [GO] 2020―Dec―31 Plant-Based Drugs and Vaccines for COVID-19 Nasir Mahmood, Sarah Bushra Nasir, Kathleen Hefferon
281 [GO] 2020―Dec―31 Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review Cheryl Lin, Pikuei Tu, Leslie M. Beitsch
282 [GO] 2020―Dec―29 Comparison of Four SARS-CoV-2 Neutralization Assays Lydia Riepler, Annika Rössler, Albert Falch, André Volland, Wegene Borena, Dorothee von Laer, Janine Kimpel
283 [GO] 2020―Dec―25 Platforms Exploited for SARS-CoV-2 Vaccine Development Shilu Mathew, Muhammed Faheem, Neeraja A. Hassain, Fatiha M. Benslimane, Asmaa A. Al Thani, Hassan Zaraket, Hadi M. Yassine
284 [GO] 2020―Dec―23 Sustained Vaccination Coverage during the Coronavirus Disease 2019 Epidemic in the Republic of Korea Jeong Hee Yu, Hang jin Jeong, Seon Ju Kim, Jae Young Lee, Young June Choe, Eun Hwa Choi, En Hi Cho
285 [GO] 2020―Dec―23 Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah
286 [GO] 2020―Dec―21 SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy) Vieri Lastrucci, Chiara Lorini, Marco Del Riccio, Eleonora Gori, Fabrizio Chiesi, Gino Sartor, et al. (+6)
287 [GO] 2020―Dec―17 Occurrence of Antibodies against SARS-CoV-2 in the Domestic Cat Population of Germany Anna Michelitsch, Donata Hoffmann, Kerstin Wernike, Martin Beer
288 [GO] 2020―Dec―17 A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine Weina Sun, Stephen McCroskery, Wen-Chun Liu, Sarah R. Leist, Yonghong Liu, Randy A. Albrecht, et al. (+10)
289 [GO] 2020―Dec―16 Vaccination Criteria Based on Factors Influencing COVID-19 Diffusion and Mortality Ilaria Spassiani, Lorenzo Gubian, Giorgio Palé, Giovanni Sebastiani
290 [GO] 2020―Dec―16 Potency of an Inactivated Influenza Vaccine against a Challenge with A/Swine/Missouri/A01727926/2015 (H4N6) in Mice for Pandemic Preparedness Hirotaka Hayashi, Norikazu Isoda, Enkhbold Bazarragchaa, Naoki Nomura, Keita Matsuno, Masatoshi Okamatsu, et al. (+2)
291 [GO] 2020―Dec―15 Is a COVID-19 Vaccine Likely to Make Things Worse? Stéphanie M. C. Abo, Stacey R. Smith
292 [GO] 2020―Dec―09 Navigating the Quagmire: Comparison and Interpretation of COVID-19 Vaccine Phase 1/2 Clinical Trials Luca Tudor Giurgea, Matthew James Memoli
293 [GO] 2020―Dec―07 Efforts at COVID-19 Vaccine Development: Challenges and Successes Azizul Haque, Anudeep B. Pant
294 [GO] 2020―Dec―03 The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments Paolo Gisondi, Francesco Bellinato, Andrea Chiricozzi, Giampiero Girolomoni
295 [GO] 2020―Dec―01 Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey Alexander Domnich, Maura Cambiaggi, Alessandro Vasco, Luca Maraniello, Filippo Ansaldi, Vincenzo Baldo, et al. (+9)
296 [GO] 2020―Dec―01 Covid-19-Associated Pulmonary Aspergillosis: The Other Side of the Coin Claudio Costantini, Frank L. van de Veerdonk, Luigina Romani
297 [GO] 2020―Nov―20 Immunogenetic Association Underlying Severe COVID-19 Kendall McCoy, Autumn Peterson, Yun Tian, Yongming Sang
298 [GO] 2020―Nov―18 COVID-19 Infection Detection and Prevention by SARS-CoV-2 Active Antigens: A Synthetic Vaccine Approach José Manuel Lozano, Luz Mary Salazar, Ángela Torres, Adriana Arévalo-Jamaica, Carlos Franco-Muñoz, Marcela Mercado-Reyes, Fabio Ancizar Aristizabal
299 [GO] 2020―Nov―16 Antibody Responses to SARS-CoV-2 Antigens in Humans and Animals Hyunsuh Kim, Patrick Seiler, Jeremy C. Jones, Granger Ridout, Kristi P. Camp, Thomas P. Fabrizio, et al. (+10)
300 [GO] 2020―Nov―13 Association between Exposure to Influenza Vaccination and COVID-19 Diagnosis and Outcomes Pietro Ragni, Massimiliano Marino, Debora Formisano, Eufemia Bisaccia, Stefania Scaltriti, Emanuela Bedeschi, Roberto Grilli
301 [GO] 2020―Nov―12 SARS-CoV-2 Proteins Induce IFNG in Th1 Lymphocytes Generated from CD4+ Cells from Healthy, Unexposed Polish Donors Anna Sałkowska, Iwona Karwaciak, Kaja Karaś, Jarosław Dastych, Marcin Ratajewski
302 [GO] 2020―Nov―10 Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses Monia Makhoul, Houssein H. Ayoub, Hiam Chemaitelly, Shaheen Seedat, Ghina R. Mumtaz, Sarah Al-Omari, Laith J. Abu-Raddad
303 [GO] 2020―Nov―04 Rapid High-Yield Production of Functional SARS-CoV-2 Receptor Binding Domain by Viral and Non-Viral Transient Expression for Pre-Clinical Evaluation Omar Farnós, Alina Venereo-Sánchez, Xingge Xu, Cindy Chan, Shantoshini Dash, Hanan Chaabane, et al. (+5)
304 [GO] 2020―Nov―03 COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response Swati Jain, Himanshu Batra, Poonam Yadav, Subhash Chand
305 [GO] 2020―Nov―02 Conjugation of Human β-Defensin 2 to Spike Protein Receptor-Binding Domain Induces Antigen-Specific Protective Immunity against Middle East Respiratory Syndrome Coronavirus Infection in Human Dipeptidyl Peptidase 4 Transgenic Mice Ju Kim, Ye Lin Yang, Yongsu Jeong, Yong-Suk Jang
306 [GO] 2020―Nov―02 Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model Aymn T. Abbas, Sherif A. El-Kafrawy, Sayed Sartaj Sohrab, Ashraf A. Tabll, Ahmed M. Hassan, Naoko Iwata-Yoshikawa, et al. (+2)
307 [GO] 2020―Oct―30 Mass Spectrometric Characterization of Narcolepsy-Associated Pandemic 2009 Influenza Vaccines Aditya Ambati, Guo Luo, Elora Pradhan, Jacob Louis, Ling Lin, Ryan D. Leib, et al. (+4)
308 [GO] 2020―Oct―26 Development and Evaluation of Vero Cell-Derived Master Donor Viruses for Influenza Pandemic Preparedness Po-Ling Chen, Tsai-Teng Tzeng, Alan Yung-Chih Hu, Lily Hui-Ching Wang, Min-Shi Lee
309 [GO] 2020―Oct―17 The Strange Case of BCG and COVID-19: The Verdict Is Still up in the Air Radha Gopalaswamy, Natarajan Ganesan, Kalamani Velmurugan, Vivekanandhan Aravindhan, Selvakumar Subbian
310 [GO] 2020―Oct―15 Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers Iván Martínez-Baz, Camino Trobajo-Sanmartín, Irati Arregui, Ana Navascués, Marta Adelantado, Juan Indurain, et al. (+3)
311 [GO] 2020―Oct―08 Evolutionary Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reveals Genomic Divergence with Implications for Universal Vaccine Efficacy Nanda Kumar Yellapu, Shachi Patel, Bo Zhang, Richard Meier, Lisa Neums, Dong Pei, et al. (+11)
312 [GO] 2020―Oct―06 Host Receptors of Influenza Viruses and Coronaviruses-Molecular Mechanisms of Recognition Nongluk Sriwilaijaroen, Yasuo Suzuki
313 [GO] 2020―Oct―03 Impact of the COVID-19 Pandemic on Routine Childhood Immunization in Saudi Arabia Mohammed Alsuhaibani, Aqeel Alaqeel
314 [GO] 2020―Oct―03 Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States Kendall Pogue, Jamie L. Jensen, Carter K. Stancil, Daniel G. Ferguson, Savannah J. Hughes, Emily J. Mello, et al. (+4)
315 [GO] 2020―Oct―03 Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection Sang Heui Seo, Yunyueng Jang
316 [GO] 2020―Oct―01 Relationship between Citizens’ Health Engagement and Intention to Take the COVID-19 Vaccine in Italy: A Mediation Analysis Guendalina Graffigna, Lorenzo Palamenghi, Stefania Boccia, Serena Barello
317 [GO] 2020―Sep―24 Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death Robert Root-Bernstein
318 [GO] 2020―Sep―23 Impact of COVID-19 on Immunization Services for Maternal and Infant Vaccines: Results of a Survey Conducted by Imprint-The Immunising Pregnant Women and Infants Network Anja Saso, Helen Skirrow, Beate Kampmann
319 [GO] 2020―Sep―19 Pneumocystis jirevocii and SARS-CoV-2 Co-Infection: A Common Feature in Transplant Recipients? Maria A. De Francesco, Federico Alberici, Nicola Bossini, Francesco Scolari, Federico Pascucci, Gabriele Tomasoni, Arnaldo Caruso
320 [GO] 2020―Sep―17 Relationship between Influenza Vaccination Coverage Rate and COVID-19 Outbreak: An Italian Ecological Study Mauro Amato, José Pablo Werba, Beatrice Frigerio, Daniela Coggi, Daniela Sansaro, Alessio Ravani, et al. (+4)
321 [GO] 2020―Sep―16 Evaluation of Antibody Response Directed against Porcine Reproductive and Respiratory Syndrome Virus Structural Proteins Hung Q. Luong, Huong T. L. Lai, Hiep L. X. Vu
322 [GO] 2020―Sep―07 Porcine Reproductive and Respiratory Syndrome Virus Interferes with Swine Influenza A Virus Infection of Epithelial Cells Georges Saade, Déborah Ménard, Caroline Hervet, Patricia Renson, Erika Hue, Jianzhong Zhu, et al. (+8)
323 [GO] 2020―Aug―31 Interferon Inducing Porcine Reproductive and Respiratory Syndrome Virus Vaccine Candidate Protected Piglets from HP-PRRSV Challenge and Evoke a Higher Level of Neutralizing Antibodies Response Yafei Li, Junhui Li, Sun He, Wei Zhang, Jian Cao, Xiaomei Pan, et al. (+4)
324 [GO] 2020―Aug―28 Can Immunization of Hens Provide Oral-Based Therapeutics against COVID-19? José M. Pérez de la Lastra, Victoria Baca-González, Patricia Asensio-Calavia, Sergio González-Acosta, Antonio Morales-delaNuez
325 [GO] 2020―Aug―27 Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China Jiahao Wang, Rize Jing, Xiaozhen Lai, Haijun Zhang, Yun Lyu, Maria Deloria Knoll, Hai Fang
326 [GO] 2020―Aug―25 Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2 Gabriel N. A. Rego, Mariana P. Nucci, Arielly H. Alves, Fernando A. Oliveira, Luciana C. Marti, Leopoldo P. Nucci, et al. (+2)
327 [GO] 2020―Aug―24 A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2 Mohammed A. Rohaim, Muhammad Munir
328 [GO] 2020―Aug―24 The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: Data from the EPICOVID19 Web-Based Survey Marianna Noale, Caterina Trevisan, Stefania Maggi, Raffaele Antonelli Incalzi, Claudio Pedone, Mauro Di Bari, et al. (+9)
329 [GO] 2020―Aug―07 Invited Editorial: Despite COVID-19, Influenza Must Not Be Relegated to “Only the Sniffles” Graham Pawelec
330 [GO] 2020―Aug―06 Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies Zafar Mahmood, Hani Alrefai, Helal F. Hetta, Hidaya A. Kader, Nayla Munawar, Sheikh Abdul Rahman, et al. (+3)
331 [GO] 2020―Aug―06 SARS-CoV-2 Consensus-Sequence and Matching Overlapping Peptides Design for COVID19 Immune Studies and Vaccine Development Alex Olvera, Marc Noguera-Julian, Athina Kilpelainen, Luis Romero-Martín, Julia G. Prado, Christian Brander
332 [GO] 2020―Jul―28 Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics Approach Noor Rahman, Fawad Ali, Zarrin Basharat, Muhammad Shehroz, Muhammad Kazim Khan, Philippe Jeandet, et al. (+3)
333 [GO] 2020―Jul―23 Immunogenic SARS-CoV-2 Epitopes: In Silico Study Towards Better Understanding of COVID-19 Disease-Paving the Way for Vaccine Development Vipin Ranga, Erik Niemelä, Mahlet Z. Tamirat, John E. Eriksson, Tomi T. Airenne, Mark S. Johnson
334 [GO] 2020―Jul―22 COVID-19: Mechanisms of Vaccination and Immunity Daniel E. Speiser, Martin F. Bachmann
335 [GO] 2020―Jul―20 Identification and Analysis of Unstructured, Linear B-Cell Epitopes in SARS-CoV-2 Virion Proteins for Vaccine Development Andrés Corral-Lugo, Mireia López-Siles, Daniel López, Michael J. McConnell, Antonio J. Martin-Galiano
336 [GO] 2020―Jul―15 Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes Ferdinand Zettl, Toni Luise Meister, Tanja Vollmer, Bastian Fischer, Jörg Steinmann, Adalbert Krawczyk, et al. (+5)
337 [GO] 2020―Jul―14 Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis Danielle Klinger, Ido Blass, Nadav Rappoport, Michal Linial
338 [GO] 2020―Jul―03 Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design Dongliang Wang, Jinhui Mai, Wenfeng Zhou, Wanting Yu, Yang Zhan, Naidong Wang, et al. (+2)
339 [GO] 2020―Jun―23 SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries Hatem A. Elshabrawy
340 [GO] 2020―Jun―19 Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients Subbaya Subramanian, Tinen Iles, Sayeed Ikramuddin, Clifford J. Steer
341 [GO] 2020―Jun―17 Vaccines against Coronaviruses: The State of the Art Cristiano Conte, Francesco Sogni, Paola Affanni, Licia Veronesi, Alberto Argentiero, Susanna Esposito
342 [GO] 2020―Jun―16 E. coli-Produced Monophosphoryl Lipid a Significantly Enhances Protective Immunity of Pandemic H1N1 Vaccine Quyen Thi Nguyen, Eunjin Kim, Jihyun Yang, Chankyu Lee, Da Hui Ha, Choon Geun Lee, et al. (+2)
343 [GO] 2020―Jun―12 A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults Irina Kiseleva, Irina Isakova-Sivak, Marina Stukova, Marianna Erofeeva, Svetlana Donina, Natalie Larionova, et al. (+12)
344 [GO] 2020―Jun―10 Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2 Mariangela Garofalo, Monika Staniszewska, Stefano Salmaso, Paolo Caliceti, Katarzyna Wanda Pancer, Magdalena Wieczorek, Lukasz Kuryk
345 [GO] 2020―Jun―09 Immunoinformatics and Structural Analysis for Identification of Immunodominant Epitopes in SARS-CoV-2 as Potential Vaccine Targets Sumit Mukherjee, Dmitry Tworowski, Rajesh Detroja, Sunanda Biswas Mukherjee, Milana Frenkel-Morgenstern
346 [GO] 2020―May―27 The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation Parakkal Jovvian George, Wanbo Tai, Lanying Du, Sara Lustigman
347 [GO] 2020―May―20 Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic Vicente Clemente-Suárez, Alberto Hormeño-Holgado, Manuel Jiménez, Juan Benitez-Agudelo, Eduardo Navarro-Jiménez, Natalia Perez-Palencia, et al. (+3)
348 [GO] 2020―May―14 Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19 Sara Lega, Samuele Naviglio, Stefano Volpi, Alberto Tommasini
349 [GO] 2020―May―14 A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity? Sung-Jae Kim, Van-Giap Nguyen, Yong-Ho Park, Bong-Kyun Park, Hee-Chun Chung
350 [GO] 2020―May―08 Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now? Steven Rockman, Karen Laurie, Ian Barr
351 [GO] 2020―Apr―15 What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19? Sergio Rosales-Mendoza, Verónica A. Márquez-Escobar, Omar González-Ortega, Ricardo Nieto-Gómez, Jaime I. Arévalo-Villalobos
352 [GO] 2020―Mar―31 Progress and Prospects on Vaccine Development against SARS-CoV-2 Jinyong Zhang, Hao Zeng, Jiang Gu, Haibo Li, Lixin Zheng, Quanming Zou


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.116 sec